Acceptance of COVID 19 vaccine among sub-Sahara African (SSA): a comparative study of residents and diaspora dwellers

The COVID-19 vaccines are being rolled out across all the Sub-Saharan Africa (SSA) countries, with countries setting targets for achieving full vaccination rates. The aim of this study was to compare the uptake of, resistance and hesitancy to the COVID-19 vaccine between SSA locally residents and in the diaspora. This was a cross-sectional study conducted using a web and paper-based questionnaire to obtain relevant information on COVID-19 vaccine acceptance. The survey items included questions on demography, uptake and planned acceptance or non-acceptance of the COVID-19 vaccines among SSAs. Multinomial logistic regression was used to determine probabilities of outcomes for factors associated with COVID-19 vaccination resistance and hesitancy among SSA respondents residing within and outside Africa. Uptake of COVID-19 vaccines varied among the local (14.2%) and diaspora (25.3%) residents. There was more resistance to COVID-19 vaccine among locals (68.1%) and across the sociodemographic variables of sex [ adjusted Relative Risk (ARR) =0.73, 95% CI; 0.58 - 0.93], primary/less [ARR =0.22, 95% CI; 0.12 - 0.40] and bachelors degree [ARR =0.58, 95% CI; 0.43 - 0.77] educational levels, occupation [ARR =0.32, 95% CI; 0.25 - 0.40] and working status [ARR =1.40, 95%CI; 1.06 - 1.84]. COVID-19 vaccine hesitancy was almost similar between locals and diasporas (17.7% and 17.8% respectively) significant only among healthcare workers [ARR =0.46, 95% CI; 0.16 - 1.35] in the diaspora after adjusting for the variables. Similarly, knowledge and perception of COVID-19 vaccine among locals were substantial, but only perception was remarkable to resistance [ARR =0.86, 95% CI; 0.82 - 0.90] and hesitancy [ARR =0.85, 95% CI; 0.80 - 0.90] of the vaccine. Differences exist in the factors that influence COVID-19 vaccine acceptance between local SSA residents and those in the diaspora. Knowledge about COVID-19 vaccines affects the uptake, resistance, and hesitancy to the COVID-19 vaccine. Information campaigns focusing on the efficacy and safety of vaccines could lead to improved acceptance of COVID-19 vaccines.

Africans living locally and those in the diaspora (mostly living in Western countries) during 144 the lockdown, [37] suggests there could be similarities in their acceptance of the COVID-19 145 vaccination. This study, therefore, sought to investigate the differences in the acceptance of  Study setting and population 164 The study population included adults who were 18 years and older and were of sub- 165 Saharan Africans residing locally (in Africa) and in diaspora (outside of Africa). Respondents 166 from several countries in SSA, mostly from Cameroun, Ghana, Nigeria, South Africa, 167 Tanzania, and those in diaspora mostly living in Australia, United Kingdom, United States, 168 Saudi Arabia, Canada, China, and India took part in this study. 169 Sample size determination 170 The sample size was determined using Cochran's formulae (n = z 2 pq/d 2 ) with the 171 assumption of a proportion of 50% at a confidence level of 95% with an error margin of 172 2.5%. A 20% non-response rate was assumed, and a minimum sample size of 2401 was 173 obtained. 175 This was a web-based cross-sectional survey carried out between 14 th of March and 176 17 th of May 2021. Due to the continued COVID-19 lockdowns in many of the target 177 countries at the time of this study, web-based study was most appropriate even though it may 178 have excluded some participants with no access to internet-based phone/computer services.

179
The survey instrument and data collection 180 Data was collected using a validated self-administered questionnaire adapted from a 181 previous study.
[39] The survey tool was tested for the internal validity of the items, and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 19 (S1 Table). The exposure variable was the 'place of residence' (local or diaspora).

198
The COVID-19 vaccine knowledge items had 10 questions on a Likert scale with five 199 levels as indicated in SI Table 1. The scores for nine of the items ranged from 0 (lowest) to 4 200 (highest) while, for one item, it was coded as 1 for Yes and 0 for No. The overall knowledge 201 towards COVID-19 vaccination score ranged from 0 -37 points, with a higher knowledge 202 score indicating a better knowledge towards COVID-19 vaccination.

203
The attitude towards the COVID-19 vaccine items included four items with each 204 assigned 2 points for 'yes', 1 point for 'unsure' and 0 point for 'No'. The total attitude score 205 ranged from 0 to 8, with a higher score denoting a better attitude towards COVID-19 206 vaccination.

207
The risk perception for contracting the disease after vaccination included questions on 208 how the participants rate their risk of becoming infected with the virus and risk of dying from 209 the infection. The responses were structured using a Likert scale with five levels (S1 Table), 210 with scores for each item ranging from 0 (lowest) to 4 (highest). The total perception score . CC-BY 4.0 International license It is made available under a perpetuity.
is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint and charts using frequencies, percentages, mean and standard deviations as required.  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

236
Characteristics of the respondents 237 There was a total of 2545 SSA respondents [2391 locals (93.9%) and 154 in the 238 diaspora (6.1%)]. Table 1 shows the frequency and percentage distribution of respondents 239 according to their socio-demographic variables. The majority of the SSA local residents 240 (67.8%) were younger than 38 years, while those in the diaspora were older. There were more 241 females than males in both groups, and the majority were originally from West Africa (locals 242 55.6%, diaspora 75.4%). More than half (56.9%) of the locals were not married, and 59.7% 243 from the diaspora were married. Many locals had a bachelors' degree (56.9%), and most 244 diaspora participants were postgraduate degree holders (53.3%). Most respondents from both 245 groups were employed /self-employed were predominantly non-healthcare workers and were 246 of the Christian faith. More than 80% of locals and above 90% of those in the diaspora had 247 been previously vaccinated for one or two other conditions. More than two-thirds of the 248 respondents indicated that they have never smoked. The proportion of respondents with 249 preexisting conditions was high among locals (84.6%) and diaspora (69.5%). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint   is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

294
Higher mean scores for attitude and perception were observed among the COVID-19 295 vaccine uptake respondents for the local residents, while the mean knowledge score was 296 highest for the hesitant group. Among the diasporas, the mean knowledge and perception 297 scores were similarly highest in uptake respondents, but a higher score for attitude was 298 observed in the hesitancy respondents ( is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The purpose of this study was to compare the uptake, resistance and hesitancy of the 374 COVID-19 vaccine between the local residents and diaspora dwellers in SSA region of the 375 African continent. Uptake of the COVID-19 vaccine was found to be twice as high among 376 residents in the diaspora compared to local SSA residents. The WHO and Centers for Disease  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint   is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ;   is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint  is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint   is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint The copyright holder for this this version posted March 18, 2022. ; https://doi.org/10.1101/2022.03.16.22272510 doi: medRxiv preprint